CompanyAiHealth
insitro
insitro is a machine-learning-driven drug discovery and development company that uses high-content human data, cellular models and AI to find better targets and design better medicines. Founded in 2018 by Daphne Koller, the company runs its own therapeutic pipeline and partners with large pharma on programs in ALS, metabolic disease and oncology.
2018Founded
South San FranciscoHQ
$400MSeries C
techbiodrug discoverymachine learningaigenomicsbiotech